Study guide
17.3 Dialysis Unit Infection Control & Environmental Safety
BONENT Certified Hemodialysis Nurse CHN
Track your progress as you read
Finished sections get a check mark.
1 Exam Orientation
1.1 Current CHN Exam Facts and Study Strategy
2 Chapter 1: Renal Anatomy, Physiology & CKD Pathophysiology
2.1 Nephron Physiology & Endocrine Functions 2.2 Acute Kidney Injury & Chronic Kidney Disease Staging 2.3 Fluid, Electrolyte & Acid-Base Imbalances in ESRD
3 Chapter 2: CKD-MBD, Uremia & Clinical Manifestations
3.1 CKD-Mineral and Bone Disorder (CKD-MBD) 3.2 Uremic Syndrome & Multi-System Complications 3.3 Dialysis Patient Education & Nutritional Management
4 Individualized Nursing Care
4.1 Nursing Assessment, Planning and Evaluation 4.2 Treatment Records and Safe Handoffs 4.3 Psychosocial Assessment, Counseling and Referral
5 Chapter 3: Principles of Hemodialysis & Dialysate Chemistry
5.1 Transport Mechanisms: Diffusion, Convection & Ultrafiltration 5.2 Dialyzer Characteristics, Membrane Biocompatibility & Flux 5.3 Dialysate Composition & Concentrate Formulations 5.4 Hemodialysis Adequacy: Urea Kinetics, Kt/V & URR
6 Chapter 4: Vascular Access: Fistulas, Grafts & Catheters
6.1 Arteriovenous Fistulas & Arteriovenous Grafts 6.2 Physical Examination, Surveillance & Monitoring of Access 6.3 Central Venous Catheters & CDC Infection Prevention
7 Chapter 5: Cannulation Practice & Access Complications
7.1 Cannulation Techniques: Rope-Ladder, Buttonhole & Needle Sizing 7.2 Vascular Access Stenosis, Thrombosis & Steal Syndrome 7.3 Access Infiltration, Pseudoaneurysms & Hemorrhage Management
8 Chapter 6: Hemodialysis Treatment Delivery & Circuit Monitoring
8.1 Pre-Dialysis Assessment, Target Dry Weight & UFR Limits 8.2 Extracorporeal Circuit Setup, Priming & Safety Alarms 8.3 Anticoagulation Management: Heparin Protocols & Citrate 8.4 Treatment Termination, Hemostasis & Post-Dialysis Assessment
9 Equipment and Laboratory Skills
9.1 Ancillary Equipment and Bedside Safety 9.2 Blood Sampling, Laboratory Trends and Critical Results
10 Chapter 7: Acute Intradialytic Complications & Emergencies
10.1 Intradialytic Hypotension & Muscle Cramping 10.2 Dialysis Disequilibrium Syndrome & Neurological Events 10.3 Dialyzer Reactions & Hypersensitivity (Type A and Type B) 10.4 Critical Emergencies: Air Embolism, Hemolysis & Blood Loss
11 Extended and Acute Treatment
11.1 Sequential UF, Hemofiltration and Hemoperfusion 11.2 Acute Kidney Injury and High-Risk Dialysis Initiation
12 Chapter 8: Nephrology Pharmacology in Hemodialysis
12.1 Anemia Management: ESAs & Intravenous Iron Therapy 12.2 CKD-MBD Pharmacotherapy: Binders, Vitamin D & Calcimimetics 12.3 Cardiovascular, Antimicrobial & Dialyzable Drug Dosing
13 Home and Peritoneal Dialysis
13.1 Home Dialysis Selection and Adult Learning 13.2 Home Setup, Monitoring and Emergency Readiness 13.3 Peritoneal Dialysis Principles and Nursing Care
14 Kidney Transplantation
14.1 Transplant Benefits, Burdens and Modality Counseling 14.2 Transplant Indications, Contraindications and Referral 14.3 Pretransplant Workup and Waiting-List Coordination 14.4 Immunosuppressants, Interactions and Patient Teaching 14.5 Returning to Dialysis After Graft Failure 14.6 New-Graft Monitoring and Urgent Changes
15 Chapter 9: Water Treatment Systems & Dialyzer Reprocessing
15.1 AAMI/ISO Water Treatment Architecture & Components 15.2 Chemical Contaminant Monitoring & Total Chlorine Testing 15.3 Microbiological Standards, Endotoxin Surveillance & Sampling 15.4 Dialyzer Reprocessing Standards, Testing & Germicide Safety
16 Clinical Unit Management
16.1 Evaluating Dialysis Technology and Supplies 16.2 Staffing, Personnel Policies and Standards of Care
17 Chapter 10: Supervision, Administration & Professional Practice
17.1 RN Delegation, Technician Supervision & Nurse Practice Acts 17.2 CMS Conditions for Coverage & Interdisciplinary Care Planning 17.3 Dialysis Unit Infection Control & Environmental Safety 17.4 Quality Improvement (ESRD QIP), Ethics & Palliative Care
18 Professional Development
18.1 Professional Literature, Organizations and Continuing Learning 18.2 Research Design, Implementation and Evidence Interpretation 18.3 Staff Training, Competency and Remediation
19 Environmental Hazards and Emergency Planning
19.1 Chemical Agents, Disinfection and Exposure Control 19.2 Biological Hazards and Occupational Injury Response 19.3 Fire, Threats and Power or Water Interruptions
17.3 Dialysis Unit Infection Control & Environmental Safety
Key Takeaways Explain This Topic AI
Perform hand hygiene and change gloves between patients and between contaminated and clean tasks.
Clean and disinfect an empty station using a compatible EPA-registered product for its labeled wet time.
HBV-positive patients require dedicated equipment and separation from susceptible patients according to CDC/CMS rules.
Dialysis hepatitis B vaccine schedules are product-specific: Engerix-B four doses, Recombivax HB dialysis formulation three doses.
HCV and HIV do not require dedicated machines or automatic same-patient reuse exclusion.
Last updated: October 2026
Dialysis Unit Infection Control & Environmental Safety
Maintenance hemodialysis patients are profoundly immunocompromised and face an extraordinary risk of healthcare-associated infections ( HAIs ). Infections are a major cause of morbidity and mortality in the ESRD population. Multiple factors drive this vulnerability: uremia-induced immune dysfunction (blunted cellular immunity, impaired phagocytic killing, and neutrophil chemotaxis defects), frequent vascular access punctures (hundreds per patient annually), foreign body vascular catheters, and close spatial proximity in outpatient treatment bays where up to 24 patients dialyze simultaneously. Stringent adherence to the CDC Dialysis Infection Control Recommendations and CMS Conditions for Coverage 42 CFR § 494.30 is mandatory to prevent cross-contamination and deadly outbreaks.
Personal Protective Equipment (PPE) & Hand Hygiene Mandates
Standard hospital precautions are inadequate in the outpatient hemodialysis environment; specialized dialysis-specific infection control precautions must be enforced across all clinical interactions.
Required Personal Protective Equipment (PPE)
Protective clothing: Use a gown or apron appropriate to expected blood/body-fluid exposure and chemical tasks. Change contaminated PPE and follow facility precautions; one garment configuration is not mandatory for every routine contact.
Facial Protection : Use a mask and eye/face protection when blood splash or spray is anticipated, including relevant connection, disconnection and cannulation tasks. Catheter-care masking also follows the approved aseptic protocol. The selected protection must fit the task and exposure.
Disposable Gloves : Clean, non-sterile gloves must be worn for all patient contact, access handling, machine setting adjustments, and station cleaning.
Hand Hygiene & Glove Stewardship
The CDC emphasizes that contaminated staff gloves are the primary vector for pathogen transmission in dialysis units.
Mandatory Hand Hygiene Opportunities : Hands must be sanitized using an alcohol-based hand rub ( 60 % to 95 % 60\%\text{ to }95\% 60% to 95% alcohol) or washed with antimicrobial soap and water for at least 20 seconds :
Before touching a patient or cannulating an access.
Before performing clean or aseptic procedures (accessing IV lines, preparing medication).
Immediately after removing gloves.
After touching blood, body fluids, or contaminated equipment/surfaces.
When moving from a contaminated body site to a clean body site on the same patient.
Glove Change Rules : Gloves must be discarded, hand hygiene performed, and fresh gloves donned between every single patient contact, before touching clean supplies or medications, and immediately after completing station disinfection. Staff must never touch clean surfaces, computerized medical records, or clean medication carts with gloves that have touched a patient or machine.
Environmental Surface Cleaning & Facility Zonation
Cross-contamination occurs when pathogens from the treatment floor migrate into clean support areas. ESRD facilities must maintain rigorous physical segregation between clean and contaminated zones.
Physical Separation of Clean vs. Contaminated Areas
Clean Areas : Dedicated medication preparation rooms or designated clean medication areas physically separated from the dialysis floor. Biohazard waste, dirty linens, and patient blood specimens are strictly forbidden from clean areas. Medications must never be drawn up or prepared at the patient's bedside or station . Medication vials must never be carried into the patient station in pockets or on supply trays; once a medication vial enters an active patient station, it is considered contaminated and cannot be returned to clean storage.
Contaminated Areas : The patient treatment floor, dialysis stations, dialyzer reprocessing rooms, soiled utility rooms, and prime/waste drainage sinks.
Inter-Treatment Station Disinfection Protocol
Disinfection must never commence while the patient is still seated in the chair . The patient must completely vacate the station, and used bloodlines and single-use dialyzers must be contained in the designated waste stream, with needles placed directly into approved sharps containers, before surface disinfection begins.
Disinfection Scope : Thoroughly wipe down all non-porous surfaces within the station, including the dialysis machine outer housing, touchscreens, module doors, blood pump housing, treatment chair, side tables, IV poles, blood pressure cuffs, and automated vitals cables.
Disinfectant Solutions :
Routine disinfection: Select an equipment-compatible EPA-registered product and follow its labeled dilution, cleaning requirements and contact time. Household bleach concentrations vary, so an unqualified 1:100 ratio is not a dependable final concentration.
Blood spills: Wear appropriate PPE, remove visible contamination and disinfect using the compatible product and labeled blood-spill procedure. Do not improvise a concentration from an assumed household stock strength.
Wet Contact Time : The disinfectant must remain visibly wet on surfaces for the full manufacturer-specified contact time (typically between 1 and 10 minutes) before allowing the next patient to enter the station. Wiping surfaces dry prematurely with clean towels negates germicidal efficacy and constitutes a regulatory violation.
Bloodborne Pathogen Protocols: HBV, HCV & HIV
Bloodborne viral infections pose substantial risks during hemodialysis. Specialized CDC protocols apply based on pathogen transmission biology:
1. Hepatitis B Virus (HBV)
Hepatitis B is exceptionally hardy in the environment, capable of surviving on dry ambient surfaces for at least 7 days while retaining viral infectivity. Microscopic, invisible droplets of blood containing HBV can transmit infection via direct or indirect contact.
Isolation Room Mandate : Patients who test positive for Hepatitis B surface antigen ( H B s A g HBsAg H B s A g positive ) must be dialyzed in a separate, dedicated isolation room .
Use the required separate room or regulatory exception arrangement and a dedicated dialysis machine. Room setup follows the applicable facility and infection-control requirements.
The patient must have dedicated clinical equipment (dedicated blood pressure cuff, stethoscope, and thermometer) that never leaves the room.
The patient must be assigned dedicated staff members who do not care for HBV-susceptible patients during the same treatment shift.
Susceptible Patient Management ( H B s A g HBsAg H B s A g negative, a n t i − H B s < 10 mIU/mL anti-HBs < 10\text{ mIU/mL} an t i − H B s < 10 mIU/mL ) :
Dialysis vaccination: Engerix-B uses 40 micrograms at 0, 1, 2 and 6 months; Recombivax HB dialysis formulation uses 40 micrograms at 0, 1 and 6 months. Heplisav-B safety and effectiveness have not been established in adults on HD.
Post-Vaccination Testing : Measure a n t i − H B s anti-HBs an t i − H B s titers 1 to 2 months after completing the series. A protective titer is defined as a n t i − H B s ≥ 10 mIU/mL anti-HBs \ge 10\text{ mIU/mL} an t i − H B s ≥ 10 mIU/mL .
Responder follow-up: Check anti-HBs annually and give the indicated booster when below 10 mIU/mL. CDC dialysis guidance does not require routine post-booster titers.
Monthly Testing : Susceptible patients must undergo monthly H B s A g HBsAg H B s A g screening to detect seroconversion promptly before transmission occurs.
2. Hepatitis C Virus (HCV)
Hepatitis C virus transmission occurs primarily through percutaneous blood exposure. Unlike HBV, environmental stability is lower, and cross-contamination is prevented through standard dialysis precautions.
Treatment Location : HCV-antibody or HCV-RNA positive patients are dialyzed in the general treatment area . The CDC strictly does not recommend a dedicated isolation room or dedicated dialysis machines for HCV patients, as strict adherence to barrier precautions and surface disinfection eliminates transmission.
Dialyzer Reuse : In facilities practicing dialyzer reprocessing, HCV positivity alone does not prohibit same-patient reuse when a reusable device and validated process meet the applicable requirements.
HCV surveillance in the CDC chronic-HD guidance uses anti-HCV testing at six-month intervals and monthly ALT, with confirmatory evaluation of abnormal findings.
3. Human Immunodeficiency Virus (HIV)
HIV is extremely fragile in the environment and is transmitted through percutaneous blood contact.
Treatment Location : HIV-positive patients dialyze in the general treatment floor using standard dialysis infection control precautions.
Isolation/Equipment : Neither a dedicated machine nor an isolation room is required or recommended.
Bloodborne Pathogens Comparative Protocol Table
- Pathogen Feature Hepatitis B Virus (HBV) Hepatitis C Virus (HCV) Human Immunodeficiency Virus (HIV)
- Precautions Dedicated HBV measures Dialysis infection precautions Dialysis infection precautions
Dedicated Isolation Room Mandatory for H B s A g HBsAg H B s A g -positive patients No (general treatment floor) No (general treatment floor)
Dedicated Dialysis Machine Mandatory for H B s A g HBsAg H B s A g -positive patients No (standard machine assignment) No (standard machine assignment)
Dedicated Staff Assignment Mandatory (no care of susceptible patients on shift) No No
Dialyzer Reprocessing Reuse Prohibited in almost all facilities Not excluded solely for this infection; follow validated same-patient process Not excluded solely for this infection; follow validated same-patient process
Vaccination Product-specific dialysis HBV schedule No approved vaccine No approved vaccine
Surveillance Monthly HBsAg for susceptibles; annual anti-HBs for vaccine responders Anti-HCV every six months and ALT monthly per chronic-HD guidance Testing according to applicable clinical recommendations
Use PPE based on expected contact and splash exposure, with chemical-resistant protection when handling germicides. No CDC dialysis rule mandates facial PPE merely for standing within six feet of any running circuit. Select an EPA-registered product compatible with equipment and follow its dilution and wet contact time; household bleach strength varies, so a ratio alone does not specify a dependable concentration. Hepatitis B isolation requirements have facility-history exceptions in the regulation, although a dedicated room, machine, equipment and staff separation are the standard exam scenario. Staff caring for an HBV-positive patient must not simultaneously care for susceptible patients. HCV surveillance includes anti-HCV testing at six-month intervals and monthly ALT under the CDC chronic-HD recommendations; do not describe both as semiannual. For known vaccine responders, annual anti-HBs checks and a booster when below 10 mIU/mL are recommended; routine post-booster serology is not required by the CDC dialysis recommendation.